The Liver Meeting® 2017 – The 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)

Event Date: October 20 - 24, 2017

Event Location: Booth 543, Walter E. Washington Convention Center, 810 7th St NW, Washington, DC 20001

Diapharma will be attending and exhibiting at The Liver Meeting 2017. See what’s new in CK18 biomarkers for NASH and AH research at Booth 543. CK18 plays a role in cell death. Explore M30/M65 ELISAs for measuring hepatocyte apoptosis and cell death non-invasively. Diapharma offers an extensive line of liver injury biomarkers, including K18, HA, α-GST, and Collagen IV. Research use only. Please click here to schedule a meeting with us or email us directly.

The The Liver Meeting® brings together scientists and healthcare professionals involved or interested in preventing and curing liver disease. During The Liver Meeting® 2017, more than 9500 hepatologists and hepatology health professionals from across the nation and around the world will gather in Washington, DC, to exchange the latest liver disease research, discuss treatment outcomes, and interact with colleagues at the annual, must-attend event in the science and practice of hepatology.

The The Liver Meeting® 2017 – The 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) covers topics such as:

Clinical Liver Transplantation and Liver Surgery
Clinical Hepatobiliary Neoplasia and Liver Imaging
Human Cholestatic and Autoimmune Liver Diseases
Portal Hypertension and Other Complications of Cirrhosis
Hepatotoxicity
Steatosis and Steatohepatitis
Viral Hepatitis C
Metabolic and Genetic Disease
Inflammation and Immunobiology
Hepatitis B
Pediatric Hepatology
Acute Liver Failure and Artificial Liver Support
Liver Fibrogenesis and Non-Parenchymal Cell Biology
Experimental Liver Transplantation and Liver Surgery
Cell and Molecular Biology
Experimental Hepatobiliary Neoplasia
Biliary Physiology, Transport, Cholangiocyte Biology, Experimental Cholestasis